Remnant-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome

Journal of Clinical Lipidology

Volumn 5, Issue 5, 2011, Pages 395-400

  Kotani, Kazuhiko ^a,b   Asahara Satoh, Noriko ^a   Kato, Yasuhisa ^c   Araki, Rika ^d   Himeno, Akihiro ^a   Yamakage, Hajime ^a   Koyama, Kazunori ^e,f   Tanabe, Makito ^d   Oishi, Mariko ^g   Okajima, Taiichiro ^d   Shimatsu, Akira ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^f International University of Health and Welfare Mita Hospital   (Japan)

^g Oishi Clinic   (Japan)

Author keywords

Metabolic syndrome; Obesity; Oxidized LDL; Remnant; RLP C; SAA LDL

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; SMOKING HABIT;

ADULT; AGE FACTORS; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; SERUM AMYLOID A PROTEIN; SEX FACTORS; SMOKING; TRIGLYCERIDES;

EID: 80053913090     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.08.001     Document Type: Article

References (27)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
2. S. Mottillo, K.B. Filion, and J. Genest The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 2010 1113 1132
3. G.E. Sonnenberg, G.R. Krakower, and A.H. Kissebah A novel pathway to the manifestations of metabolic syndrome Obes Res 12 2004 180 186 (Pubitemid 41132540)
4. Y. Matsuzawa The metabolic syndrome and adipocytokines FEBS Lett 580 2006 2917 2921 (Pubitemid 43729162)
5. H. Katagiri, T. Yamada, and Y. Oka Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals Circ Res 101 2007 27 39 (Pubitemid 47094621)
6. N.G. Abraham, E.J. Brunner, J.W. Eriksson, and R.P. Robertson Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes Ann N Y Acad Sci 1113 2007 256 275 (Pubitemid 350015014)
7. A. Shah, N. Mehta, and M.P. Reilly Adipose inflammation, insulin resistance, and cardiovascular disease JPEN J Parenter Enteral Nutr 32 2008 638 644
8. Y. Homma Predictors of atherosclerosis J Atheroscler Thromb 11 2004 265 270
9. J.C. Fruchart, M.C. Nierman, E.S. Stroes, J.J. Kastelein, and P. Duriez New risk factors for atherosclerosis and patient risk assessment Circulation 109 2004 S15 S19
10. K. Nakajima, T. Nakano, and A. Tanaka The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma Clin Chim Acta 367 2006 36 47
11. K. Miyauchi, N. Kayahara, and M. Ishigami Development of a homogeneous assay to measure remnant lipoprotein cholesterol Clin Chem 53 2007 2128 2135 (Pubitemid 350197296)
12. D.C. Chan, G.F. Watts, P.H. Barrett, F.H. O'Neill, T.G. Redgrave, and G.R. Thompson Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome Clin Sci 104 2003 383 388 (Pubitemid 36458064)
13. A. Satoh, H. Adachi, and M. Tsuruta High plasma level of remnant-like particle cholesterol in the metabolic syndrome Diabetes Care 28 2005 2514 2518 (Pubitemid 41384303)
14. T. Nakamura, H. Takano, and K. Umetani Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome Atherosclerosis 181 2005 321 327 (Pubitemid 41019613)
15. T. Nakamura, J.E. Obata, and H. Takano High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis Atherosclerosis 202 2009 234 240
16. K. Kotani, N. Satoh, T. Yamada, and A. Gugliucci The potential of serum amyloid A-LDL as a novel biomarker for cardiovascular disease risk Clin Lipid 5 2010 489 495
17. K. Ogasawara, S. Mashiba, and Y. Wada A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease Atherosclerosis 174 2004 349 356 (Pubitemid 38597093)
18. K. Kotani, N. Satoh, and Y. Kato A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome Atherosclerosis 204 2009 526 531
19. N. Satoh, A. Shimatsu, and K. Kotani Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome Hypertens Res 32 2009 1004 1008
20. M. Granér, J. Kahri, and T. Nakano Impact of postprandial lipidaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease Eur J Clin Invest 36 2006 764 770 (Pubitemid 44569964)
21. A. Yoshida, Y. Matsutani, Y. Fukuchi, K. Saito, and M. Naito Analysis of the factors contributing to serum retinol binding protein and transthyretin levels in Japanese adults J Atheroscler Thromb 13 2006 209 215
22. M. Hiki, K. Shimada, and H. Ohmura Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease J Cardiol 53 2009 108 116
23. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity Circ J 66 2002 987 992
24. D.F. Vine, D.R. Glimm, and S.D. Proctor Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome Atheroscler Suppl 9 2008 69 76
25. M. Adiels, S.O. Olofsson, M.R. Taskinen, and J. Borén Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 1225 1236
26. P. Holvoet, D. De Keyzer, and D.R. Jacobs Oxidized LDL and the metabolic syndrome Future Lipidol 3 2008 637 649
27. N. Watanabe, T. Taniguchi, and H. Taketoh Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients Diabetes Care 22 1999 152 156 (Pubitemid 29028313)